Changes in 5-HT receptor binding induced by tetrahydrocannabinol metabolites in bovine cerebral cortex

被引:0
|
作者
Kimura, T
Yamamoto, I
Ohta, T
Yoshida, H
Watanabe, K
Ho, IK
Yoshimura, H
机构
[1] HOKURIKU UNIV,FAC PHARMACEUT SCI,DEPT HYG CHEM,KANAZAWA,ISHIKAWA 92011,JAPAN
[2] UNIV MISSISSIPPI,MED CTR,DEPT PHARMACOL & TOXICOL,JACKSON,MS 39216
[3] NAKAMURA GAKUEN UNIV,DEPT FOOD & NUTR,JOHNAN KU,FUKUOKA 81401,JAPAN
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Effects of four cannabinoids, Delta(8)-tetrahydrocannabinol (Delta(8)-THC), 11-hydroxy-Delta(8)-THC (11-OH-Delta(8)-THC), 11-oxo-Delta(8)-THC, and Delta(8)-THC-11-oic acid, on the bindings of [H-3]5-HT and [H-3]ketanserin to bovine synaptic membrane were examined by ligand binding assay. Both 11-OH-Delta(8)-THC and 11-oxo-Delta(8)-THC, which are psychopharmacologically active metabolites, significantly decreased the specific [H-3]5-HT binding to the membrane. Scatchard analyses indicated that 11-OH-Delta(8)-THC caused significant increase in the KD value with changes in Bmax, whereas 11-oxo-Delta(8)-THC caused significant increase only in the KD value. On the other hand, Delta(8)-THC-11-oic acid, an inactive metabolite, did not alter specific [H-3]5-HT binding. The results also indicated that all cannabinoids did not alter the specific [H-3]ketanserin binding. The present study reveals that the pharmacological activity of THC may be partially mediated through the active metabolites of THC on serotonergic receptors.
引用
收藏
页码:57 / 69
页数:13
相关论文
共 50 条
  • [41] POSTNATAL-DEVELOPMENT OF 5-HT1 RECEPTORS - [H-3]5-HT BINDING-SITES AND 5-HT INDUCED ADENYLATE-CYCLASE ACTIVATIONS IN RAT-BRAIN CORTEX
    ZIFA, E
    HERNANDEZ, J
    FAYOLLE, C
    FILLION, G
    DEVELOPMENTAL BRAIN RESEARCH, 1988, 44 (01): : 133 - 140
  • [42] LITHIUM ENHANCEMENT OF CENTRAL 5-HT TRANSMISSION INDUCED BY 5-HT PRECURSORS
    SANGDEE, C
    FRANZ, DN
    BIOLOGICAL PSYCHIATRY, 1980, 15 (01) : 59 - 75
  • [43] MULTIPLE 5-HT TERMINAL AUTORECEPTORS IN GUINEA-PIG CEREBRAL-CORTEX DEMONSTRATED BY INVITRO [H-3] 5-HT RELEASE
    PRICE, GW
    WATSON, J
    ROBERTS, C
    JONES, BJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 : P101 - P101
  • [44] 5-HT receptor modulation of anxiety
    Lanfumey, L.
    Martin, C. P. B.
    Hamon, M.
    Mongeau, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S225 - S225
  • [45] QUINPIROLE - A 5-HT RECEPTOR ANTAGONIST
    AHLENIUS, S
    HILLEGAART, V
    WIJKSTROM, A
    NEUROSCIENCE LETTERS, 1991, 126 (01) : 57 - 59
  • [46] SUBCLASSIFICATION OF PRESYNAPTIC 5-HT AUTORECEPTORS IN THE HUMAN CEREBRAL-CORTEX AS 5-HT1D-BETA RECEPTORS
    FINK, K
    ZENTNER, J
    GOTHERT, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 352 (04) : 451 - 454
  • [47] THE 5-HT TERMINAL AUTORECEPTOR IS A 5-HT1D RECEPTOR SUBTYPE IN THE GUINEA-PIG CORTEX
    ROBERTS, C
    WATSON, J
    BURTON, M
    PRICE, GW
    MULHOLLAND, K
    MIDDLEMISS, DN
    JONES, BJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U113 - U113
  • [48] A functional genetic variation of the 5-HT transporter affects 5-HT1A receptor binding in humans
    Murthy, NY
    David, S
    Rabiner, EA
    Johnstone, E
    Jacob, R
    Walton, R
    Grasby, PM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2004, 18 (03) : A68 - A68
  • [49] Migraine is associated with high brain 5-HT levels as indexed by 5-HT4 receptor binding
    Deen, Marie
    Hougaard, Anders
    Hansen, Hanne D.
    Svarer, Claus
    Eiberg, Hans
    Lehel, Szabolcs
    Knudsen, Gitte M.
    Ashina, Messoud
    CEPHALALGIA, 2019, 39 (04) : 526 - 532
  • [50] Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women
    M Lee
    U F Bailer
    G K Frank
    S E Henry
    C C Meltzer
    J C Price
    C A Mathis
    K T Putnam
    R E Ferrell
    A R Hariri
    W H Kaye
    Molecular Psychiatry, 2005, 10 : 715 - 716